(Q37349299)

English

Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites

scientific article published on 26 May 2009

In more languages
default for all languages
No label defined

No description defined

Statements

Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit